Erroneous uses of NSAIDs in patients with COVID-19, Dengue, and Chikungunya
Clinical Sciences and Clinical Research · 2023
DOI: 10.58489/2836-8959/002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Sciences and Clinical Research, 2023. Verfasst von Abdul Kader Mohiuddin.
Abstract (Originalsprache)
NSAIDs are considered the mainstay of current therapies for viral arthropathies, albeit they frequently only offer partial relief. Numerous studies have documented widespread abuse of NSAIDs among Covid-19, Dengue, and Chikungunya patients. NSAIDs can be used to treat severe arthralgia, however the WHO advises against doing so in suspected Chikungunya patients until it has been determined that they do not have dengue. Acetaminophen is recommended by consensus guidelines for treating Dengue fever from the WHO and CDC, although NSAIDs are contraindicated due to a possible increase in bleeding risk, which could result in thrombocytopenia as a side effect.
Zitieren
APA
Mohiuddin, A. K. (2023). Erroneous uses of NSAIDs in patients with COVID-19, Dengue, and Chikungunya. Clinical Sciences and Clinical Research. https://doi.org/10.58489/2836-8959/002
Vancouver
Mohiuddin AK. Erroneous uses of NSAIDs in patients with COVID-19, Dengue, and Chikungunya. Clinical Sciences and Clinical Research. 2023. doi:10.58489/2836-8959/002
BibTeX
@article{Mohiuddin2023,
author = {Mohiuddin, Abdul Kader},
title = {Erroneous uses of NSAIDs in patients with COVID-19, Dengue, and Chikungunya},
journal = {Clinical Sciences and Clinical Research},
year = {2023},
doi = {10.58489/2836-8959/002}
}
EUVIMED